| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts Lancet 386 (9988), 31-45, 2015 | 1772* | 2015 |
| Principles and practice of pediatric infectious disease SS Long, LK Pickering, CG Prober Elsevier Health Sciences, 2012 | 430 | 2012 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites RTS, S Clinical Trials Partnership (2014) PLoS medicine 11 (7), e1001685, 2014 | 369 | 2014 |
| Hospitalizations associated with COVID-19 among children and adolescents—COVID-NET, 14 states, March 1, 2020–August 14, 2021 MJ Delahoy MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 317 | 2021 |
| Risk factors for severe COVID-19 in children FHCNET 31. Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J ... Pediatrics 149 (1), e2021053418, 2022 | 280 | 2022 |
| Malaria rapid diagnostic tests in elimination settings—can they find the last parasite? ML McMorrow, M Aidoo, SP Kachur Clinical Microbiology and Infection 17 (11), 1624-1631, 2011 | 247 | 2011 |
| Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 states, July 2021–January 2022 KJ Marks MMWR. Morbidity and mortality weekly report 71, 2022 | 230 | 2022 |
| Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2023 M Melgar MMWR. Morbidity and mortality weekly report 72, 2023 | 200 | 2023 |
| Outbreak of variant influenza A (H3N2) virus in the United States MA Jhung, S Epperson, M Biggerstaff, D Allen, A Balish, N Barnes, ... Clinical infectious diseases 57 (12), 1703-1712, 2013 | 200 | 2013 |
| Challenges in routine implementation and quality control of rapid diagnostic tests for malaria–Rufiji District, Tanzania ML McMorrow, MI Masanja, SMK Abdulla, E Kahigwa, SP Kachur The American journal of tropical medicine and hygiene 79 (3), 385, 2008 | 194 | 2008 |
| Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—nine states, January–September 2021 PJ Embi MMWR. Morbidity and mortality weekly report 70, 2021 | 188 | 2021 |
| COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US States, January 2021 to April 2022 FP Havers, H Pham, CA Taylor, M Whitaker, K Patel, O Anglin, ... JAMA internal medicine 182 (10), 1071-1081, 2022 | 185 | 2022 |
| Effectiveness of mRNA vaccination in preventing COVID-19–associated invasive mechanical ventilation and death—United States, March 2021–January 2022 MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 174 | 2022 |
| Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015. M McMorrow | 161 | 2006 |
| Seasonality of respiratory syncytial virus—United States, 2017–2023 S Hamid MMWR. Morbidity and Mortality Weekly Report 72, 2023 | 149 | 2023 |
| SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21 C Cohen, J Kleynhans, A von Gottberg, ML McMorrow, N Wolter, ... The Lancet Infectious Diseases 22 (6), 821-834, 2022 | 138 | 2022 |
| Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization … JM Jones MMWR. Morbidity and mortality weekly report 72, 2023 | 137 | 2023 |
| Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19–like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity—nine states, January … CH Bozio MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 133 | 2021 |
| Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020 S Tempia, S Walaza, JN Bhiman, ML McMorrow, J Moyes, T Mkhencele, ... Eurosurveillance 26 (29), 2001600, 2021 | 132 | 2021 |
| Effectiveness of COVID-19 mRNA vaccines against COVID-19–associated hospitalization—five veterans affairs medical centers, United States, February 1–August 6, 2021 KL Bajema MMWR. Morbidity and mortality weekly report 70, 2021 | 118 | 2021 |
Cheryl CohenNational Institute for Communicable DiseasesEmail verificata su nicd.ac.za